Projects per year
Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.
Stephen Falk, Simon Gollins, John Staffurth, R Ray, Andrew Bridgewater, J Ian Geh, Jane Blazeby, Georgina Griffiths
Research output: Contribution to journal › Article (Academic Journal) › peer-review
33 Citations (Scopus)
267 Downloads (Pure)